Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats

Life Sciences

Volumn 62, Issue 25, 1998, Pages 2295-2302

  Guo, Xiang ^a   Ding, Yun Min ^a   Hu, Jiang Yuan ^a   Jin, Guo Zhang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

D1 dopamine receptors; D2 dopamine receptors; Fos immunohistochemistry; HRP retrograde tracing; Stepholidine

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; HORSERADISH PEROXIDASE; OXIDOPAMINE; PROTEIN C FOS; QUINPIROLE; STEPHOLIDINE; BERBERINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; GLOBUS PALLIDUS; IMMUNOREACTIVITY; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; RAT; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; REFERENCE VALUE; SPRAGUE DAWLEY RAT;

ANIMALIA; ARMORACIA RUSTICANA;

ANIMALS; BERBERINE; CORPUS STRIATUM; DENERVATION; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HORSERADISH PEROXIDASE; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REFERENCE VALUES;

EID: 0032523225     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00210-0     Document Type: Article

References (25)

1. 1. S.X. XU, L.P. YU, Y.R. HAN, Y. CHEN, G.Z. JIN, Acta Pharmacol. Sin. 10 104-10 (1989).
2. 2. Z.D. ZHANG, G.Z. JIN, S.X. XU, L.P. YU, Y. CHEN, F.Y. JIANG, Y.R. ZHANG, Acta Pharmacol. Sin. 7 522-526 (1986).
3. 3. K.X. HUANG, B.C. SUN, G.Z. JIN, Acta Pharmacol. Sin. 13 17-22 (1992).
4. 4. X. GUO, L.M. WANG, J. LIU, G.Z. JIN, Acta Pharmacol. Sin. 18 225-230 (1997).
5. 5. Z.J. DONG, X. GUO, L.J. CHEN, G.Z. JIN, Life Sci. 61 465-472 (1997).
6. 6. X. GUO, J. LIU, L.L. ZOU, J. JIN, B.C. WANG, G.Z. JIN, Acta Pharmacol. Sin. 19 100-103 (1998).
7. 7. B.C. SUN, X.X. ZHANG, G.Z. JIN, Life Sci. 59 299-306 (1996).
8. 8. X. GUO, L.J. CHEN, M. BUDA, G.Z. JIN, Acta Pharmacol. Sin. 13 289-292 (1992).
9. 9. Z.J. DONG, G.Z. JIN, H.Y. HUANG, Acta Pharmacol. Sin 6 497-501 (1995).
10. 10. L.L. ZOU, Y. CHEN, Y.Y. SONG, G.Z. JIN, Acta Pharmacol. Sin. 17311-314 (1996).
11. 11. K.X. HUANG, G.Z. JIN, Sci. Sin. [B] 7 738-743 (1991).
12. 12. B.C. SUN, G.Z. JIN, Acta Pharmacol. Sin. 13 395-399 (1992).
13. 13. M. SHENG, M. GREENBERG, Neuron 4 477-485 (1990).
14. 14. M. DRAGUNOW, G.S. ROBERTSON, R.L.M. FAULL, H.A. ROBERTSON, K. JANSEN, Neurosci. 37 287-294 (1990).
15. 15. H.A. ROBERTSON, M.R. PETERSON, K. MURPHY, G.S. ROBERTSON, Brain Res. 503 346-349 (1989).
16. 16. C.R. GERFEN, T.M. ENGBER, Z. SUSEL, T.N. CHASE, L.C. MAHAN, F. MONSMA, D.R. SIBLEY, Science 250 1429-1432 (1990).
17. 17. G.S. ROBERTSON, S.R. VINCENT, H.C. FIBIGER, Neurosci. 49 285-296 (1992).
18. 18. G.A. GONZALEZ, M.R. MONTMINY, Cell 59 675-680 (1989).
19. 19. J.M. SIMPSON, J.Q. WANG, J.F. McGINTY, Neurosci. 69 441-457(1995).
20. 20. BOYSON, P. MCGONIGLE, P.B. MOLINOFF, J. Neurosci. 6 3177-3188 (1986).
21. 21. R.L. ALBIN, A.B. YOUNG, J.B. PENNEY, Trends Neurosci. 12 366-374 (1989).
22. 22. B.Y. ZENG, J. JOLKKONEN, P. JENNER, C.D. MARSDEN, Neurosci. 66 19-28 (1995).
23. 23. B. GOMEZ-MANCILLA, P.J. BEDARD, J. Pharmacol. Exp. Ther. 259 409-413 (1991).
24. 24. P. BLANCHET, P.J. BEDARD, D.R. BRITTON, J.W. KEBABIAN, J. Pharmacol. Exp. Ther. 267 275-279 (1993).
25. 25. X.G. ZHANG, D.K. LIU, Y.L. WU, Z. HONG, Chinese J. Neuropsychiat. 15 16-17 (1989).